血浆炎症标志物在晚年抑郁症及向痴呆转化中的作用:一项3年随访研究
该研究比较了136例晚年抑郁症住院患者与103名认知健康非抑郁对照者的12种血浆炎症标志物水平,并在PRODE队列中随访3年,探索炎症标志物及临床特征能否预测痴呆转化。结果发现部分炎症标志物在晚年抑郁症患者中显著升高,但无一能预测痴呆转化;仅治疗反应差显著预测痴呆进展风险升高。
要点
- 晚年抑郁症患者IL-1ra、CCL-2、CCL-4、IFN-γ和IL-17a水平在多数模型中显著高于认知健康对照。
- 在PRODE队列中,随访3年时36例(25.9%)发展为痴呆,但无一炎症标志物预测痴呆转化。
- 临床特征中仅治疗反应差显著预测晚年抑郁症向痴呆进展的风险升高。
核心结论
- 晚年抑郁症患者部分血浆炎症标志物水平显著高于认知健康对照,但炎症标志物未能预测3年内向痴呆的转化,仅治疗反应差显著预测痴呆进展风险升高。
研究设计与样本
- 比较136例晚年抑郁症住院患者(PRODE队列)与103名认知健康非抑郁对照者(COGNORM队列)的12种血浆炎症标志物水平,采用逐步校正的多元线性回归。
- PRODE队列中139例患者有随访数据(其中123例有基线血浆炎症标志物数据),采用Cox比例风险回归探索炎症标志物及晚年抑郁症临床特征是否预测随访期间向痴呆的进展。
主要发现
- IL-1ra、CCL-2、CCL-4、IFN-γ和IL-17a水平在多数模型中晚年抑郁症患者显著高于对照。
- PRODE队列随访3年时36例(25.9%)发展为痴呆(有细胞因子数据者中n=31)。
- PRODE队列中无一炎症标志物预测晚年抑郁症向痴呆的进展。
- 晚年抑郁症临床特征中仅治疗反应差显著预测向痴呆进展的风险升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Late-life depression (LLD) has been linked to increased likelihood of dementia, although mechanisms responsible for this association remain largely unknown. One feature frequently observed in both LLD and dementia is elevated levels of plasma inflammatory markers. The present study aimed to compare the levels of 12 plasma inflammatory markers between older people with LLD and controls, and to explore whether these markers, along with clinical characteristics, can predict dementia in patients with LLD within 3 years of follow-up. Using multiple linear regression with stepwise adjustment, we compared levels of plasma inflammatory markers (IL-1β, IL-1ra, IL-6, IL-10, IL-17a, IL-18, IL-33, TNFα, CD40L, IFN-γ, CCL-2 and CCL-4) between 136 inpatients with LLD (PRODE cohort) and 103 cognitively healthy non-depressed controls (COGNORM cohort). In the PRODE cohort, follow-up data was available for 139 patients (of them 123 had data on baseline plasma inflammatory markers); 36 (25.9%) developed dementia by Year 3 (n = 31 for those with cytokine data). Using Cox proportional hazards regression, we explored whether inflammatory markers and clinical characteristics of LLD (age of onset, treatment response, number of episodes) predicted progression to dementia during follow-up. Levels of IL-1ra, CCL-2, CCL-4, IFN-γ and IL-17a were significantly higher in LLD patients compared to controls in the majority of models. However, none of the inflammatory markers predicted progression from LLD to dementia in the PRODE cohort. Among clinical features, only poor response to treatment significantly predicted higher risk of progression to dementia.
引用
- Bocharova M, Borza T, Watne LO, et al. The role of plasma inflammatory markers in late-life depression and conversion to dementia: a 3-year follow-up study. Mol Psychiatry. 2025. PMID: 39922907. doi:10.1038/s41380-025-02908-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。